Tuesday, December 23, 2014
Recent changes in drug labels: The following drugs had modifications to the contraindications, warnings or precautions section of their labels: Adcetris (brentuximab vedotin) for Injection; Arava (leflunomide) Tablets; AVELOX (moxifloxacin hydrochloride) Tablets and IV; Bosulif (bosutinib) Tablets; Cardizem (diltiazem hydrochloride) Tablets; Cubicin (daptomycin for injection) Intravenous; Cymbalta (duloxetine) Delayed-release Capsules; Foscavir (foscarnet sodium) Injection; Lopid (gemfibrozil) Tablets; Mycobutin (rifabutin) Capsules; Mytelase (ambenonium chloride) Tablets; Sensipar (cinacalcet hydrochloride) Tablets; Sovaldi (sofosbuvir) Tablet; Sylatron (peginterferon alfa-2b); Taxotere (docetaxel) Injection Concentrate; Unasyn (ampicillin sodium/sulbactam sodium) Injection; Votrient (pazopanib hydrocholoride) Tablets and Zelboraf (vemurafenib) Tablet. Click here for more information from the FDA.
Robert Pear, for the New York Times, reported on a study which revealed that half of the physicians listed as serving Medicaid patients were unavailable either because they were not actually taking Medicaid patients or because the information about their medical practice was outdated.
Robert Preidt, for Health Day, discussed a study in the Annals of Epidemiology that indicated that despite lower smoking rates, cigarettes are still responsible for 3 out of 10 cancer deaths in the United States.
Marie Ellis, with Medical News Today, reported on an article in JAMA Pediatrics which found that children diagnosed with autism spectrum disorder were twice as likely to be born with mothers with preeclampsia during pregnancy.